|
DR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.364400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.774600E-01 |
| Normal-vs-Stage2 |
1.357720E-02 |
| Normal-vs-Stage3 |
4.235800E-01 |
| Normal-vs-Stage4 |
4.567800E-01 |
| Stage1-vs-Stage2 |
1.694260E-02 |
| Stage1-vs-Stage3 |
5.816200E-01 |
| Stage1-vs-Stage4 |
6.357800E-01 |
| Stage2-vs-Stage3 |
7.819700E-02 |
| Stage2-vs-Stage4 |
1.096640E-01 |
| Stage3-vs-Stage4 |
9.657800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.328600E-01 |
| Normal-vs-AfricanAmerican |
6.720600E-01 |
| Normal-vs-Asian |
5.364200E-01 |
| Caucasian-vs-AfricanAmerican |
5.290200E-01 |
| Caucasian-vs-Asian |
7.630800E-01 |
| AfricanAmerican-vs-Asian |
4.189000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.554100E-02 |
| Normal-vs-Female |
5.801600E-01 |
| Male-vs-Female |
1.266960E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.211800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.411600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.944100E-02 |
| Normal-vs-Age(81-100Yrs) |
7.293600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.769600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.216090E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.638000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.069400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.943400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.890800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.741200E-01 |
| Classical-VS-Follicular |
1.28800003995622E-09 |
| Classical-VS-Other |
3.261000E-01 |
| Classical-VS-Normal |
5.417800E-01 |
| Tall-VS-Follicular |
8.18610000000719E-05 |
| Tall-VS-Other |
3.204400E-01 |
| Tall-VS-Normal |
5.808600E-01 |
| Follicular-VS-Other |
2.886800E-01 |
| Follicular-VS-Normal |
2.09969999999116E-05 |
| Other-VS-Normal |
3.724200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.205700E-02 |
| Normal-vs-N1 |
4.973000E-01 |
| N0-vs-N1 |
3.253600E-01 |
|
|
